With a lack of innovation in the field of animal medicine, new tools are needed to keep production animals and pets healthy and productive.
Harnessing the microbiome to discover and develop novel probiotics, microbiome-derived bioactives, and engineered microbial therapeutics.
Anterra helped orchestrate the spinout from Elanco and participated in the Series A financing. Co-investors and partners include Viking Global, Elanco, Ginkgo Bioworks & The Ferment Fund, and Nutreco.
Our other companies
Food marketplace helping people eat better effortlessly
Digital procurement platform for farm inputs and services
Innovative materials to extend fresh produce shelf life
Real-time data collection tools for farm machinery
Financial and data services for the fresh produce industry
Next-generation synthetic cellular controls
Drug discovery using machine learning
Genome engineering using CRSPR-Cas9
Novel flavor generation using modified brewer’s yeast
Plant-based enteral nutrition products